Home ProductsMedical Testing Supplies

HIV Rapid Test with 15-minute HIV-1/HIV-2/HIV-O Rapid Test with High sensitivity and specificity

Certification
China Sichuan Hundred Medcal Technology Co., Ltd. certification
China Sichuan Hundred Medcal Technology Co., Ltd. certification
I'm Online Chat Now

HIV Rapid Test with 15-minute HIV-1/HIV-2/HIV-O Rapid Test with High sensitivity and specificity

HIV Rapid Test with 15-minute HIV-1/HIV-2/HIV-O Rapid Test with High sensitivity and specificity
HIV Rapid Test with 15-minute HIV-1/HIV-2/HIV-O Rapid Test with High sensitivity and specificity HIV Rapid Test with 15-minute HIV-1/HIV-2/HIV-O Rapid Test with High sensitivity and specificity

Large Image :  HIV Rapid Test with 15-minute HIV-1/HIV-2/HIV-O Rapid Test with High sensitivity and specificity

Product Details:
Place of Origin: CHINA
Brand Name: HDRMEDICO
Certification: CE
Model Number: /
Payment & Shipping Terms:
Minimum Order Quantity: 500pcs
Price: Negotiable
Packaging Details: Carton
Delivery Time: 10-15days
Payment Terms: L/C,T/T,Westen Union,Money Gram,Paypal/VTB
Supply Ability: 100000pc/month
Contact Now Chat Now

HIV Rapid Test with 15-minute HIV-1/HIV-2/HIV-O Rapid Test with High sensitivity and specificity

Description
Product Name: HIV-1/HIV-2/HIV-O Rapid Test Material: Plastic
Product Category: In Vitro Diagnosis Test Duration: 15 Minutes
Shelf Life: Two Years Function: Infectious Disease Detection
Highlight:

15-minute test duration HIV Rapid Test

,

Multi-type detection HIV Antibody Test

,

High sensitivity and specificity HIV-1/HIV-2/HIV-O Test

HIV-1/HIV-2/HIV-O Rapid Test All-Group HIV Antibody Test
The HIV-1/HIV-2/HIV-O Rapid Test is an advanced diagnostic reagent utilizing rapid immunochromatographic technology for qualitative detection of Human Immunodeficiency Virus (HIV) antibodies and antigens in human blood samples including whole blood, serum, or plasma. This comprehensive test simultaneously differentiates infections caused by HIV-1, HIV-2, and HIV-O (Group O) subtypes, providing critical information for early screening and viral typing.
Core Detection Capabilities:
The reagent employs multi-antibody coating technology to simultaneously detect:
  • HIV-1 Antibodies/Antigens: Covers major epidemic subtypes including Group M and rare variants
  • HIV-2 Antibodies: Specifically detects HIV-2 infection while avoiding cross-reactivity with HIV-1
  • HIV-O Antibodies: Designed for Group O strains, addressing potential missed detection by traditional reagents
Application Scenarios:
Suitable for various healthcare settings including medical institutions, disease control centers, blood donation sites, and emergency screening scenarios:
  • Early screening and typing confirmation in high-risk populations
  • Blood safety testing prior to donation procedures
  • Epidemiological surveys and strain monitoring programs
Technical Features of HIV-1/HIV-2/HIV-O Rapid Test:
  • High Sensitivity and Specificity: Utilizes combined detection strategy with recombinant antigens and monoclonal antibodies for reliable detection even in low-concentration samples
  • Rapid Results: Readable within 15-20 minutes without specialized equipment requirements
  • Simplified Operation: Supports direct testing with whole blood, minimizing sample pre-processing steps
  • Room Temperature Stability: Reagent can be stored and transported at ambient temperature conditions
Result Interpretation:
Positive results require confirmation via Western Blot (WB) or nucleic acid tests. Typing indications provide valuable guidance for subsequent viral load testing and treatment strategy selection.
Clinical Value of HIV-1/HIV-2/HIV-O Rapid Test:
Preliminary HIV typing through a single test significantly improves detection efficiency, particularly for precise prevention and control in regions where HIV-2 and Group O strains are prevalent. Typing information aids in optimizing antiviral treatment strategies and provides essential data support for public health surveillance.
Important Note: This product is intended for screening purposes only and must not be used as a definitive diagnostic tool. All operations must strictly follow established biosafety protocols. Positive samples should be reported according to regulatory requirements and forwarded to confirmation laboratories for further testing.

Contact Details
Sichuan Hundred Medcal Technology Co., Ltd.

Contact Person: Mr. Terry

Tel: 15008220675

Send your inquiry directly to us (0 / 3000)